Stocks

The table gives an overview of all stocks, alphabetically sorted.
 C&F Financial Corporation CFFI Mar 1, 2021 43.50 0.00   
 C.H. Robinson Worldwide, Inc. CHRW Mar 1, 2021 92.22 +1.51   
 C3.ai Inc AI Mar 1, 2021 121.05 0.00   
 C4 Therapeutics, Inc. CCCC Mar 1, 2021 42.39 -1.23   
 CA Healthcare Acquisition Corp. - Unit CAHCU Mar 1, 2021 10.17 0.00   
 Cabaletta Bio, Inc. CABA Mar 1, 2021 11.47 +5.52   
 Cabana Target Drawdown 10 ETF TDSC Mar 1, 2021 24.80 +1.22   
 Cabana Target Drawdown 13 ETF TDSD Mar 1, 2021 25.46 +1.42   
 Cabana Target Drawdown 16 ETF TDSE Mar 1, 2021 26.12 +2.14   
 Cabana Target Drawdown 5 ETF TDSA Mar 1, 2021 24.12 +0.90   
 Cabana Target Drawdown 7 ETF TDSB Mar 1, 2021 24.01 +1.14   
 Cable One, Inc. CABO Mar 1, 2021 1 924.44 +0.50   
 Cabot Corporation CBT Mar 1, 2021 50.71 +3.01   
 Cabot Oil & Gas Corp. COG Mar 1, 2021 18.86 +1.89   
 CACI International, Inc. Class A CACI Mar 1, 2021 226.92 +2.52   
 Cactus, Inc. Class A WHD Mar 1, 2021 34.38 +7.88   
 Cadence Bancorporation Class A CADE Mar 1, 2021 21.66 +5.56   
 Cadence Design Systems, Inc. CDNS Mar 1, 2021 147.44 +4.50   
 Cadiz, Inc. CDZI Mar 1, 2021 11.02 +1.38   
 Cae Inc. CAE Mar 1, 2021 29.95 +13.15   
 Caesars Entertainment, Inc. CZR Mar 1, 2021 94.06 +0.66   
 Caesarstone Ltd. - Ordinary Shares CSTE Mar 1, 2021 12.84 +1.82   
 Cai International Inc FXDFR PRF PERPETUAL USD 25 - Ser A CAI-A Mar 1, 2021 26.02 -0.12   
 Cai International Inc FXDFR PRF PERPETUAL USD 25 - Ser B CAI-B Mar 1, 2021 26.14 -0.83   
 CAI International, Inc. CAI Mar 1, 2021 43.35 -1.48   
 Cal-Maine Foods, Inc. CALM Mar 1, 2021 38.22 +0.32   
 Caladrius Biosciences, Inc. CLBS Mar 1, 2021 1.92 +7.87   
 Calamos Convertible and High Income Fund CHY Mar 1, 2021 15.56 +2.30   
 Calamos Convertible Opportunities and Income Fund CHI Mar 1, 2021 14.72 +2.44   
 Calamos Dynamic Convertible & Income Fund - CCD Mar 1, 2021 33.62 +5.29   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK